News
RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited ...
A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...
A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" that safely triggers potent immune responses against hard-to-treat cancers, ...
The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
During the 2024 season, Verlander struggled greatly, going 5-6 and only logging 90 ⅓ innings with a 5.48 ERA, a 4.78 FIP, and a 7.37 K/9. Those are poor numbers for a three-time Cy Young Award ...
Interleukin 1 (IL-1) is a 17 kDa protein highly conserved through evolution and is a key mediator of inflammation, fever and the acute-phase response. IL-1 has important functions in the innate ...
Hosted on MSN19d
FDA Approves Tremfya for Active Crohn Disease in AdultsThis approval is the fourth indication for this dual-acting interleukin-23 inhibitor in the ... Tremfya (400 mg subcutaneous induction at weeks 0, 4, and 8) led to significantly higher clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results